Neovasc (NVCN) Shares Up 6.4%

Neovasc Inc (NASDAQ:NVCN) (TSE:NVC) shares shot up 6.4% on Tuesday . The stock traded as high as $0.52 and last traded at $0.50. 1,421,375 shares were traded during mid-day trading, a decline of 26% from the average session volume of 1,930,198 shares. The stock had previously closed at $0.47.

Several research firms recently weighed in on NVCN. ValuEngine cut shares of Neovasc from a “buy” rating to a “hold” rating in a research report on Monday, February 4th. Zacks Investment Research cut shares of Neovasc from a “buy” rating to a “hold” rating in a research report on Wednesday, January 16th.

The stock has a market capitalization of $33.06 million, a price-to-earnings ratio of -0.18 and a beta of 1.67.



Neovasc (NASDAQ:NVCN) (TSE:NVC) last posted its quarterly earnings data on Thursday, May 9th. The medical equipment provider reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.13). The company had revenue of $0.59 million for the quarter, compared to the consensus estimate of $0.40 million. On average, research analysts expect that Neovasc Inc will post -0.25 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently modified their holdings of NVCN. Virtu Financial LLC bought a new position in Neovasc during the fourth quarter valued at approximately $38,000. Wedbush Securities Inc. bought a new position in Neovasc during the first quarter valued at approximately $53,000. Finally, Perkins Capital Management Inc. bought a new position in Neovasc during the first quarter valued at approximately $234,000. Institutional investors and hedge funds own 5.63% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Neovasc (NVCN) Shares Up 6.4%” was reported by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The original version of this piece of content can be accessed at https://dakotafinancialnews.com/2019/05/15/neovasc-nvcn-shares-up-6-4.html.

Neovasc Company Profile (NASDAQ:NVCN)

Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products.

See Also: Market Capitalization and Individual Investors

Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.